Dialysis facility ownership and epoetin dosing in hemodialysis patients: a medical economic perspective.
Cohen
Joshua T
JT
Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA. jcohen@tufts-nemc.org
Neumann
Peter J
PJ
D000554:Ambulatory Care Facilities; D000740:Anemia / Q000188:drug therapy; D004470:Economics, Medical; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage*; D006397:Hematinics / Q000008:administration & dosage*; D006801:Humans; D010067:Ownership; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000592:standards*
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa